M. van Rijn

2.9k total citations · 1 hit paper
28 papers, 1.3k citations indexed

About

M. van Rijn is a scholar working on Clinical Biochemistry, Physiology and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, M. van Rijn has authored 28 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Clinical Biochemistry, 12 papers in Physiology and 6 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in M. van Rijn's work include Metabolism and Genetic Disorders (14 papers), Diet and metabolism studies (11 papers) and Mitochondrial Function and Pathology (4 papers). M. van Rijn is often cited by papers focused on Metabolism and Genetic Disorders (14 papers), Diet and metabolism studies (11 papers) and Mitochondrial Function and Pathology (4 papers). M. van Rijn collaborates with scholars based in Netherlands, United Kingdom and Denmark. M. van Rijn's co-authors include Anita MacDonald, François Feillet, Kirsten Ahring, Amaya Bélanger-Quintana, Annet M. Bosch, Júlio César Rocha, Francjan J. van Spronsen, Maria Giżewska, Annemiek M. J. van Wegberg and Ania C. Muntau and has published in prestigious journals such as American Journal of Clinical Nutrition, PEDIATRICS and Obstetrics and Gynecology.

In The Last Decade

M. van Rijn

28 papers receiving 1.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

The complete European guidelines on phenylketonuria: diagnosis and treatment

2017 531 citations Annemiek M. J. van Wegberg, Anita MacDonald et al. Orphanet Journal of Rare Diseases profile →

Peers

Countries citing papers authored by M. van Rijn

Since Specialization

Citations

This map shows the geographic impact of M. van Rijn's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M. van Rijn with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M. van Rijn more than expected).

Fields of papers citing papers by M. van Rijn

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M. van Rijn. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M. van Rijn. The network helps show where M. van Rijn may publish in the future.

Co-authorship network of co-authors of M. van Rijn

This figure shows the co-authorship network connecting the top 25 collaborators of M. van Rijn. A scholar is included among the top collaborators of M. van Rijn based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M. van Rijn. M. van Rijn is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Regional variation in the interpretation of contact precautions for multi-drug-resistant Gram-negative bacteria: a cross-sectional survey 2024 ·Journal of Hospital Infection ·Anneke van Veen, (unknown), M. Damen, Elisabeth G. W. Huijskens, S. Paltansing, M. van Rijn, Robbert G. Bentvelsen, Jacobien Veenemans, Mark van der Linden, Martine De Vos, Juliëtte A. Severin	3
2	Contact investigations for antibiotic-resistant bacteria: a mixed-methods study of patients’ comprehension of and compliance with self-sampling requests post-discharge 2023 ·Antimicrobial Resistance and Infection Control ·(unknown), (unknown), Suzanne J. C. Verhaegh, (unknown), Vicki Erasmus, Ed F. van Beeck, (unknown), (unknown), (unknown), Marjolein Damen, Elisabeth G. W. Huijskens, S. Paltansing, M. van Rijn, Jacobien Veenemans, Martine De Vos, Juliëtte A. Severin, (unknown)	3
3	The complete European guidelines on phenylketonuria: diagnosis and treatment breakdown → 2017 ·Orphanet Journal of Rare Diseases ·Annemiek M. J. van Wegberg, Anita MacDonald, Kirsten Ahring, Amaya Bélanger-Quintana, Nenad Blau, Annet M. Bosch, Alberto Burlina, Josep M. Campistol, François Feillet, Maria Giżewska, Stephan C. J. Huijbregts, Shauna Kearney, Vincenzo Leuzzi, F. Maillot, Ania C. Muntau, M. van Rijn, Friedrich K. Trefz, J. H. Walter, Francjan J. van Spronsen	531
4	Clinical value of polymerase chain reaction in detecting group B streptococcus during labor 2017 ·Journal of obstetrics and gynaecology research ·(unknown), (unknown), M. van Rijn, (unknown)	6
5	Overweight and obesity in PKU: The results from 8 centres in Europe and Turkey 2014 ·Molecular Genetics and Metabolism Reports ·Hülya Gökmen Özel, Kirsten Ahring, Amaya Bélanger-Quintana, Katharina Dokoupil, Anna Maria Lammardo, Marianne Robert, Júlio César Rocha, Manuela Almeida, M. van Rijn, Anita MacDonald	31
6	Main issues in micronutrient supplementation in phenylketonuria 2013 ·Molecular Genetics and Metabolism ·Anna Maria Lammardo, Marianne Robert, Júlio César Rocha, M. van Rijn, Kirsten Ahring, Amaya Bélanger-Quintana, Anita MacDonald, (unknown), Hülya Gökmen Özel, Philippe Goyens, François Feillet	28
7	Micronutrient status in phenylketonuria 2013 ·Molecular Genetics and Metabolism ·Marianne Robert, Júlio César Rocha, M. van Rijn, Kirsten Ahring, Amaya Bélanger-Quintana, Anita MacDonald, Katharina Dokoupil, Hülya Gökmen Özel, Anna Maria Lammardo, Philippe Goyens, François Feillet	48
8	Adherence Issues in Inherited Metabolic Disorders Treated by Low Natural Protein Diets 2012 ·Annals of Nutrition and Metabolism ·Anita MacDonald, M. van Rijn, François Feillet, Allan M. Lund, Laurie Bernstein, Annet M. Bosch, Maria Giżewska, F. J. van Spronsen	74
9	Use of sapropterin in the management of phenylketonuria: Seven case reports 2012 ·Molecular Genetics and Metabolism ·Hülya Gökmen Özel, Anna Maria Lammardo, K Motzfeldt, Marianne Robert, Júlio César Rocha, M. van Rijn, Kirsten Ahring, Amaya Bélanger-Quintana, Anita MacDonald, Katharina Dokoupil	8
10	Biochemical Monitoring and Management During Pregnancy in Patients with Isovaleric Acidaemia is Helpful to Prevent Metabolic Decompensation 2011 ·JIMD Reports ·Daphna D.J. Habets, Nicolaas C. Schaper, (unknown), F. J. van Spronsen, M. van Rijn, Jörgen Bierau, Jaap Bakker	5
11	Nutrition in phenylketonuria 2011 ·Molecular Genetics and Metabolism ·Anita MacDonald, Júlio César Rocha, M. van Rijn, François Feillet	108
12	Diet in phenylketonuria: A snapshot of special dietary costs and reimbursement systems in 10 international centers 2011 ·Molecular Genetics and Metabolism ·Amaya Bélanger‐Quintana, Katharina Dokoupil, Hülya Gökmen-Özel, Anna Maria Lammardo, Anita MacDonald, K Motzfeldt, Maria Nowacka, Marianne Robert, M. van Rijn, Kirsten Ahring	31
13	Blood phenylalanine control in phenylketonuria: a survey of 10 European centres 2010 ·European Journal of Clinical Nutrition ·Kirsten Ahring, Amaya Bélanger-Quintana, Katharina Dokoupil, Hülya Gökmen-Özel, Anna Maria Lammardo, Anita MacDonald, K Motzfeldt, Maria Nowacka, Marianne Robert, M. van Rijn	58
14	NORMAL PROTEIN METABOLISM IN PATIENTS WITH PHENYLKETONURIA 2005 ·Data Archiving and Networked Services (DANS) ·M. van Rijn, (unknown), (unknown), Dirk‐Jan Reijngoud, Pieter J. J. Sauer, (unknown), (unknown)	2
15	Clostridium cadaveris bacteraemia: Two cases and review 2005 ·Scandinavian Journal of Infectious Diseases ·Rogier P. Schade, M. van Rijn, Henri Timmers, Anton S. M. Dofferhoff, Corné H. W. Klaassen, Jacques F. Meis	12
16	The intake of total protein, natural protein and protein substitute and growth of height and head circumference in Dutch infants with phenylketonuria 2005 ·Journal of Inherited Metabolic Disease ·Marieke Hoeksma, M. van Rijn, P.H. Verkerk, Annet M. Bosch, Mark Mulder, J. B. C. de Klerk, Tom J. de Koning, M. Estela Rubio‐Gozalbo, (unknown), P J J Sauer, F. J. van Spronsen	37
17	Adverse obstetric outcome in low- and high-risk pregnancies: predictive value of maternal serum screening 1999 ·Obstetrics and Gynecology ·M. van Rijn	55
18	Maternal serum alpha‐fetoprotein in fetal anal atresia and other gastro‐intestinal obstructions 1998 ·Prenatal Diagnosis ·M. van Rijn, (unknown), A. M. Hagenaars, G. H. A. Visser	1
19	Large daily fluctuations in plasma tyrosine in treated patients with phenylketonuria 1996 ·American Journal of Clinical Nutrition ·(unknown), Tessa van Dijk, (unknown), M. van Rijn, Dirk‐Jan Reijngoud, R. Berger, (unknown)	38
20	Plasma Phenylalanine and Tyrosine Responses to Different Nutritional Conditions (Fasting/Postprandial) in Patients With Phenylketonuria: Effect of Sample Timing 1993 ·PEDIATRICS ·Francjan J. van Spronsen, M. van Rijn, Tessa van Dijk, Gerrit Smit, Dirk‐Jan Reijngoud, R. Berger, H. S. A. Heymans	42

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact